Co-existence of relapsing polychondritis and Crohn disease treated successfully with infliximab

  • Jung H
  • Kim H
  • Kim J
  • et al.
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Relapsing polychondritis (RP) is a rare, progressive immune-mediated systemic inflammatory disease of unknown etiology, characterized by recurrent inflammation of cartilaginous structures. Approximately 30% of RP cases are associated with other autoimmune diseases. However, the co-occurrence of RP and Crohn disease (CD) has rarely been reported. Herein, we present a 35-year-old woman diagnosed with RP and CD, who was refractory to initial conventional medications, including azathioprine and glucocorticoid, but who subsequently responded to infliximab (IFX). For both diseases, remission was sustained with IFX. There has been no previous report regarding the successful treatment of co-existing RP and CD with IFX.

Cite

CITATION STYLE

APA

Jung, H.-I., Kim, H. J., Kim, J.-M., Lee, J. Y., Park, K. S., Cho, K. B., & Lee, Y. J. (2021). Co-existence of relapsing polychondritis and Crohn disease treated successfully with infliximab. Yeungnam University Journal of Medicine, 38(1), 70–73. https://doi.org/10.12701/yujm.2020.00304

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free